Brian P. Mckeon - Nov 10, 2021 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Signature
/s/ Lily J. Lu, Attorney-in-Fact for Brian P. McKeon
Stock symbol
IDXX
Transactions as of
Nov 10, 2021
Transactions value $
-$11,142,279
Form type
4
Date filed
11/12/2021, 04:29 PM
Previous filing
Nov 10, 2021
Next filing
Nov 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $1.36M +20K +76% $67.85 46.3K Nov 10, 2021 Direct
transaction IDXX Common Stock Sale -$784K -1.26K -2.72% $621.40 45.1K Nov 10, 2021 Direct F1
transaction IDXX Common Stock Sale -$3.57M -5.74K -12.75% $622.36 39.3K Nov 10, 2021 Direct F2
transaction IDXX Common Stock Sale -$931K -1.49K -3.8% $623.34 37.8K Nov 10, 2021 Direct F3
transaction IDXX Common Stock Sale -$1.34M -2.14K -5.66% $624.53 35.7K Nov 10, 2021 Direct F4
transaction IDXX Common Stock Sale -$1.45M -2.33K -6.52% $625.46 33.4K Nov 10, 2021 Direct F5
transaction IDXX Common Stock Sale -$1.14M -1.81K -5.44% $626.74 31.5K Nov 10, 2021 Direct F6
transaction IDXX Common Stock Sale -$1.87M -2.97K -9.43% $627.97 28.6K Nov 10, 2021 Direct F7
transaction IDXX Common Stock Sale -$865K -1.38K -4.81% $628.78 27.2K Nov 10, 2021 Direct F8
transaction IDXX Common Stock Sale -$549K -872 -3.21% $629.80 26.3K Nov 10, 2021 Direct F9
holding IDXX Common Stock 18.1K Nov 10, 2021 by Estony McKeon Family, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -20K -68.43% 9.23K Nov 10, 2021 Common Stock 20K $67.85 Direct F10, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $620.78 to $621.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $621.79 to $622.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $622.97 to $623.965. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $624.04 to $625.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $625.06 to $626.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at prices ranging from $626.10 to $627.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 This transaction was executed in multiple trades at prices ranging from $627.32 to $628.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8 This transaction was executed in multiple trades at prices ranging from $628.34.10 to $629.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F9 This transaction was executed in multiple trades at prices ranging from $629.46 to $630.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F10 Grant of option to buy 45,535 shares of IDEXX Laboratories, Inc. common stock that vested in five annual installments beginning February 14, 2017.
F11 Not applicable.